Compound overviews
6 min read Last updated March 7, 2026By PrimeGen Research TeamBeginner
Two peptides that appear together in most tissue-repair research preparations, with different sequences, different reported mechanisms, and different handling characteristics. A side-by-side comparison.
Two peptides that appear together in most tissue-repair research preparations, with different sequences, different reported mechanisms, and different handling characteristics. A side-by-side comparison. This guide is published by PrimeGen Co., a United States supplier of lyophilized research peptides, and covers compound overviews for laboratory research contexts only.
BPC-157 is a fifteen-residue synthetic peptide (GEPPPGKPADDAGLV) described as a partial sequence of body protection compound found in gastric juice, molecular weight approximately 1419 Da.
TB-500 is a synthetic seven-residue fragment corresponding to the actin-binding region of thymosin beta-4, molecular weight approximately 889 Da. It is not thymosin beta-4 itself, which is a 43-residue protein — a naming distinction that matters when reading literature.
The BPC-157 literature centres on angiogenic signalling through the VEGFR2-Akt-eNOS axis, nitric oxide system modulation, and growth hormone receptor expression in fibroblast models, with a large rodent gastrointestinal cytoprotection body of work.
The TB-500 literature centres on actin sequestration and cell migration: the fragment binds G-actin, and the reported effects concern cytoskeletal remodelling, keratinocyte and endothelial migration, and downregulation of inflammatory signalling in injury models.
The two act on largely non-overlapping pathways — angiogenesis and vascular signalling on one side, actin-driven cell migration on the other — which is the stated rationale for the combination preparations that appear across the tissue-repair literature.
In a study design, the combination only produces interpretable data when single-agent arms are run alongside it. Combining two compounds without controls makes any observed effect impossible to attribute.
Both are stored lyophilized at -20°C protected from light and reconstitute readily in neutral aqueous diluent without acid assistance. BPC-157 is notably acid stable relative to comparable short peptides; TB-500 is a smaller, highly soluble fragment.
Both are supplied for laboratory research use only, each against an independent purity report for the specific lot.
Compounds covered by this article, each with its own monograph, specifications and lot-specific certificate of analysis.
PrimeGen Research Team
Analytical & technical writing, PrimeGen Co.
Our library is written in-house by the same team that reviews incoming lot analytics, reads third-party certificates of analysis and maintains compound documentation. Articles are educational reference material for laboratory professionals and describe published in vitro and preclinical literature only.
Published August 3, 2025 · Last reviewed March 7, 2026
The natural continuation of this article — each piece builds on what you have just read rather than repeating it.
Trust & quality
Documentation, analytical methodology and handling practice referenced throughout the research library.
Explore further
Move from this article into the catalog, the analytical documentation behind each lot, and the policies that govern every order.